SLNO logo

Soleno Therapeutics (SLNO) Selling, General & Administrative Expenses

Annual SGA

$105.86 M
+$92.38 M+685.26%

December 1, 2024


Summary


Performance

SLNO SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSLNOexpensesmetrics:

Quarterly SGA

$37.30 M
-$11.89 M-24.18%

December 1, 2024


Summary


Performance

SLNO Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSLNOexpensesmetrics:

TTM SGA

-$1.47 B
-$175.85 M-13.63%

December 1, 2024


Summary


Performance

SLNO TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSLNOexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

SLNO Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+685.3%0.0%-1484.8%
3 y3 years+879.6%0.0%-1484.8%
5 y5 years+1427.6%0.0%-1484.8%

SLNO Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+975.4%-24.2%+1499.6%-79.3%at low
5 y5-yearat high+1427.6%-24.2%+2219.8%-153.1%at low
alltimeall timeat high+9291.5%-24.2%>+9999.0%-2467.4%at low

Soleno Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2024
$105.86 M(+685.3%)
$37.30 M(-24.2%)
$105.86 M(+45.6%)
Sep 2024
-
$49.20 M(+351.8%)
$72.70 M(+171.1%)
Jun 2024
-
$10.89 M(+28.5%)
$26.82 M(+40.4%)
Mar 2024
-
$8.47 M(+104.6%)
$19.10 M(+41.7%)
Dec 2023
$13.48 M(+36.9%)
$4.14 M(+24.8%)
$13.48 M(+14.8%)
Sep 2023
-
$3.32 M(+4.7%)
$11.74 M(+9.2%)
Jun 2023
-
$3.17 M(+11.0%)
$10.76 M(+7.0%)
Mar 2023
-
$2.85 M(+18.8%)
$10.05 M(+2.1%)
Dec 2022
$9.84 M(-8.9%)
$2.40 M(+3.0%)
$9.84 M(-1.9%)
Sep 2022
-
$2.33 M(-5.5%)
$10.04 M(-4.2%)
Jun 2022
-
$2.47 M(-6.7%)
$10.47 M(+0.0%)
Mar 2022
-
$2.64 M(+1.8%)
$10.47 M(-3.1%)
Dec 2021
$10.81 M(+23.4%)
$2.60 M(-6.2%)
$10.81 M(+3.3%)
Sep 2021
-
$2.77 M(+12.3%)
$10.46 M(+5.1%)
Jun 2021
-
$2.46 M(-17.3%)
$9.95 M(+2.2%)
Mar 2021
-
$2.98 M(+32.3%)
$9.73 M(+11.1%)
Dec 2020
$8.76 M(+26.4%)
$2.25 M(-0.2%)
$8.76 M(+7.9%)
Sep 2020
-
$2.26 M(+0.4%)
$8.12 M(+8.6%)
Jun 2020
-
$2.25 M(+12.2%)
$7.47 M(+8.0%)
Mar 2020
-
$2.00 M(+24.6%)
$6.92 M(-0.1%)
Dec 2019
$6.93 M(+5.7%)
$1.61 M(-0.4%)
$6.93 M(+3.6%)
Sep 2019
-
$1.61 M(-4.7%)
$6.69 M(+0.9%)
Jun 2019
-
$1.70 M(-15.8%)
$6.63 M(-1.1%)
Mar 2019
-
$2.01 M(+47.4%)
$6.70 M(+2.2%)
DateAnnualQuarterlyTTM
Dec 2018
$6.56 M(-0.8%)
$1.36 M(-12.4%)
$6.56 M(-4.6%)
Sep 2018
-
$1.56 M(-11.8%)
$6.88 M(-1.8%)
Jun 2018
-
$1.77 M(-5.4%)
$7.00 M(-5.8%)
Mar 2018
-
$1.87 M(+10.9%)
$7.43 M(+12.4%)
Dec 2017
$6.61 M(+8.8%)
$1.68 M(-0.1%)
$6.61 M(+2.1%)
Sep 2017
-
$1.69 M(-23.2%)
$6.47 M(+7.0%)
Jun 2017
-
$2.19 M(+109.8%)
$6.05 M(+11.2%)
Mar 2017
-
$1.05 M(-32.3%)
$5.44 M(-20.8%)
Dec 2016
$6.08 M(-22.9%)
$1.54 M(+22.6%)
$6.87 M(-8.8%)
Sep 2016
-
$1.26 M(-20.7%)
$7.53 M(-10.9%)
Jun 2016
-
$1.59 M(-35.9%)
$8.45 M(-4.0%)
Mar 2016
-
$2.48 M(+12.2%)
$8.80 M(+11.7%)
Dec 2015
$7.88 M(+170.0%)
$2.21 M(+1.2%)
$7.88 M(+14.1%)
Sep 2015
-
$2.18 M(+12.5%)
$6.91 M(+29.5%)
Jun 2015
-
$1.94 M(+24.9%)
$5.33 M(+28.4%)
Mar 2015
-
$1.55 M(+25.5%)
$4.15 M(+42.6%)
Dec 2014
$2.92 M(+98.9%)
$1.24 M(+104.0%)
$2.91 M(+55.3%)
Sep 2014
-
$606.00 K(-20.1%)
$1.88 M(+23.6%)
Jun 2014
-
$758.00 K(+142.9%)
$1.52 M(+11.3%)
Mar 2014
-
$312.00 K(+56.0%)
$1.36 M(-7.1%)
Dec 2013
$1.47 M(+30.1%)
$200.00 K(-19.4%)
$1.47 M(+15.8%)
Sep 2013
-
$248.00 K(-58.9%)
$1.27 M(+24.3%)
Jun 2013
-
$604.10 K(+45.3%)
$1.02 M(+145.3%)
Mar 2013
-
$415.90 K
$415.90 K
Dec 2012
$1.13 M
-
-

FAQ

  • What is Soleno Therapeutics annual SGA?
  • What is the all time high annual SGA for Soleno Therapeutics?
  • What is Soleno Therapeutics annual SGA year-on-year change?
  • What is Soleno Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Soleno Therapeutics?
  • What is Soleno Therapeutics quarterly SGA year-on-year change?
  • What is Soleno Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Soleno Therapeutics?
  • What is Soleno Therapeutics TTM SGA year-on-year change?

What is Soleno Therapeutics annual SGA?

The current annual SGA of SLNO is $105.86 M

What is the all time high annual SGA for Soleno Therapeutics?

Soleno Therapeutics all-time high annual SGA is $105.86 M

What is Soleno Therapeutics annual SGA year-on-year change?

Over the past year, SLNO annual SGA has changed by +$92.38 M (+685.26%)

What is Soleno Therapeutics quarterly SGA?

The current quarterly SGA of SLNO is $37.30 M

What is the all time high quarterly SGA for Soleno Therapeutics?

Soleno Therapeutics all-time high quarterly SGA is $49.20 M

What is Soleno Therapeutics quarterly SGA year-on-year change?

Over the past year, SLNO quarterly SGA has changed by $0.00 (0.00%)

What is Soleno Therapeutics TTM SGA?

The current TTM SGA of SLNO is -$1.47 B

What is the all time high TTM SGA for Soleno Therapeutics?

Soleno Therapeutics all-time high TTM SGA is -$57.10 M

What is Soleno Therapeutics TTM SGA year-on-year change?

Over the past year, SLNO TTM SGA has changed by -$1.57 B (-1484.84%)